View in EDS

Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.

Saved in:
Bibliographic Details
Title: Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
Authors: de Boer JW; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Pennings ERA; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Kleinjan A; Department of Internal Medicine, Rivierenland Hospital, Tiel, The Netherlands., van Doesum JA; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Spanjaart AM; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kuipers MT; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Adam JA; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Koens L; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Niezink AGH; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Source: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6710-6716.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37639324
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Boer+JW%22">de Boer JW</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pennings+ERA%22">Pennings ERA</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kleinjan+A%22">Kleinjan A</searchLink>; Department of Internal Medicine, Rivierenland Hospital, Tiel, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Doesum+JA%22">van Doesum JA</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Spanjaart+AM%22">Spanjaart AM</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mutsaers+PGNJ%22">Mutsaers PGNJ</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jak+M%22">Jak M</searchLink>; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Poel+MWM%22">van der Poel MWM</searchLink>; Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuipers+MT%22">Kuipers MT</searchLink>; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Adam+JA%22">Adam JA</searchLink>; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Diepstra+A%22">Diepstra A</searchLink>; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koens+L%22">Koens L</searchLink>; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Dorp+S%22">van Dorp S</searchLink>; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vermaat+JSP%22">Vermaat JSP</searchLink>; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Niezink+AGH%22">Niezink AGH</searchLink>; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Meerten+T%22">van Meerten T</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6710-6716.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37639324
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2023010665
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6710
    Titles:
      – TitleFull: Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Boer JW
      – PersonEntity:
          Name:
            NameFull: Pennings ERA
      – PersonEntity:
          Name:
            NameFull: Kleinjan A
      – PersonEntity:
          Name:
            NameFull: van Doesum JA
      – PersonEntity:
          Name:
            NameFull: Spanjaart AM
      – PersonEntity:
          Name:
            NameFull: Mutsaers PGNJ
      – PersonEntity:
          Name:
            NameFull: Jak M
      – PersonEntity:
          Name:
            NameFull: van der Poel MWM
      – PersonEntity:
          Name:
            NameFull: Kuipers MT
      – PersonEntity:
          Name:
            NameFull: Adam JA
      – PersonEntity:
          Name:
            NameFull: Diepstra A
      – PersonEntity:
          Name:
            NameFull: Koens L
      – PersonEntity:
          Name:
            NameFull: van Dorp S
      – PersonEntity:
          Name:
            NameFull: Vermaat JSP
      – PersonEntity:
          Name:
            NameFull: Niezink AGH
      – PersonEntity:
          Name:
            NameFull: Kersten MJ
      – PersonEntity:
          Name:
            NameFull: van Meerten T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2023 Nov 14
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 21
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1